Onset of luteolytic action of exogenous prostaglandinF-2α during estrous cycle in goats. 2017

Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX 77843-4475, USA. Electronic address: jromano@cvm.tamu.edu.

The objectives of these two experiments were to determine the day of onset of luteolysis after exogenous PGF-2α administration during the estrous cycle and the fertility of this synchronized estrus in goats. In the first experiment, during the breeding season, 48 Nubian does were estrous synchronized, using intravaginal sponges impregnated with a progestin, and estrus was detected by vasectomized bucks. The does were divided at random into three groups of 16 does each to be treated at days 2, 3, and 4 of the estrous cycle (estrus = day 0). Then, at each day of injection, the does were again randomly divided to receive a single dose of natural prostaglandin F-2α im (PGF-2α; 5 mg/doe; treatment [TRE] group) or sterile saline solution (control [CON] group; 1 mL/doe). Finally, the following groups were originated: TRE-2, CON-2, TRE-3, CON-3, TRE-4, and CON-4. The overall estrus response after treatment with PGF-2α (TRE group, 70.8%) was higher than saline (CON group, 12.5%, P ≤ 0.001). Estrus response for TRE-2, CON-2, TRE-3, CON-3, TRE-4, and CON-4 was 25% (2 of 8), 12.5% (1 of 8), 87.5% (7 of 8), 12.5% (1 of 8), 100% (8 of 8), and 0% (0 of 8) for the same groups, respectively. Estrus response was different between day 2 and days 3 and 4 (P ≤ 0.04) and not between day 3 and day 4 (P ≥ 0.05). In the second experiment, 15 multiparous Boer does were estrous synchronized with control internal drug release (CIDR, 300 mg progesterone = P4) and PGF-2α and randomly divided to receive one single dose of PGF-2α im at days 2, 3 or 4, after synchronized estrus (n = 5 at each day). The does were detected twice a day for estrus, and blood was collected daily for P4 determination for 11 days after the synchronized estrus. Each doe in estrus was bred by hand mating to a proven male. All the does with a functional corpus/corpora luteum/lutea (CL; ≥1.0 ng/mL of P4) responded to PGF-2α with a drop in P4 levels that either lasted only 24 h for the does that did not show estrus (0.27 ± 0.10 ng/mL; n = 4) or persisted longer in all the does that showed estrus (0.22 ± 0.18 ng/mL; n = 10; P = 0.47). Estrus response for days 2, 3, and 4 was 20% (1 of 5), 80% (4 of 5), and 100% (5 of 5), respectively (P = 0.05). The conception rate was 100%, 100%, and 80% for the same days of administration, respectively (P = 0.64). It was concluded that luteolytic action of PGF-2α begins at day 3 of the estrous cycle by inducing an ovulatory and fertile estrus in goats.

UI MeSH Term Description Entries
D010120 Oxytocics Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) Oxytocic,Oxytocic Agent,Oxytocic Drug,Uterine Stimulant,Uterine Stimulants,Oxytocic Agents,Oxytocic Drugs,Oxytocic Effect,Oxytocic Effects,Agent, Oxytocic,Agents, Oxytocic,Drug, Oxytocic,Drugs, Oxytocic,Effect, Oxytocic,Effects, Oxytocic,Stimulant, Uterine,Stimulants, Uterine
D003341 Luteolysis Degradation of CORPUS LUTEUM. In the absence of pregnancy and diminishing trophic hormones, the corpus luteum undergoes luteolysis which is characterized by the involution and cessation of its endocrine function. Corpus Luteum Regression,Luteal Regression,Regression, Corpus Luteum,Regression, Luteal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006041 Goats Any of numerous agile, hollow-horned RUMINANTS of the genus Capra, in the family Bovidae, closely related to the SHEEP. Capra,Capras,Goat
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015237 Dinoprost A naturally occurring prostaglandin that has oxytocic, luteolytic, and abortifacient activities. Due to its vasocontractile properties, the compound has a variety of other biological actions. PGF2,PGF2alpha,Prostaglandin F2,Prostaglandin F2alpha,9alpha,11beta-PGF2,Enzaprost F,Estrofan,PGF2 alpha,Prostaglandin F2 alpha,9alpha,11beta PGF2,F2 alpha, Prostaglandin,F2alpha, Prostaglandin,alpha, PGF2
D030762 Estrous Cycle The period of cyclic physiological and behavior changes in non-primate female mammals that exhibit ESTRUS. The estrous cycle generally consists of 4 or 5 distinct periods corresponding to the endocrine status (PROESTRUS; ESTRUS; METESTRUS; DIESTRUS; and ANESTRUS). Cycle, Estrous,Cycles, Estrous,Estrous Cycles

Related Publications

Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
May 1972, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
December 1988, Experimental and clinical endocrinology,
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
July 1971, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
August 2005, The Journal of reproduction and development,
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
March 1997, Theriogenology,
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
November 1982, Prostaglandins,
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
January 2023, Anatomical record (Hoboken, N.J. : 2007),
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
December 1994, Steroids,
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
January 1967, Journal of animal science,
Juan E Romano, and Abdalhamid Alkar, and Marcel Amstalden
May 1965, Journal of animal science,
Copied contents to your clipboard!